CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Improvement in risk as AstraZeneca COVID trials resume can it drive sustainable market direction?

Market Overview

The dollar has started the new trading week slightly on the backfoot, with a slightly improved appetite for risk forming this morning. After causing a stir last week on a pause in its vaccination trials, the AstraZeneca/Oxford University collaboration for a COVID vaccine has resumed. Although there has been little real move through bond markets, there is a mild improvmenet in equity markets and the dollar is slipping back. This move may be tempered due to comments from Repbulican leaders over the weekend that suggested a fiscal package agreement seemed to not “look that good right now”. Having digested a dollar rebound and equities decline in recent weeks, broad markets have begun to form ranging conditions in recent sessions and this looks set to continue today.

Wall Street closed a mixed session just a shade higher on Friday with the S&P 500 +0.1% higher (at 3341). US futures are though pulling decisively higher with the E-mini S&Ps +1.1%. Asian markets were higher overnight with the Nikkei +0.6% and Shanghai Composite +0.3%. European markets look towards mildly positive early moves with FTSE Futures +0.1% and DAX Futures +0.4%. In forex with a better feel to risk appetite